Human diversity of killer cell immunoglobulin-like receptors and disease
暂无分享,去创建一个
[1] E. Thomas,et al. History, Current Results, and Research in Marrow Transplantation , 2015, Perspectives in biology and medicine.
[2] T. Beddoe,et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B , 2011, Nature.
[3] P. Parham,et al. Variable NK Cell Receptors Exemplified by Human KIR3DL1/S1 , 2011, The Journal of Immunology.
[4] Y. Kerdiles,et al. The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells. , 2011, International immunology.
[5] E. Romeo,et al. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. , 2011, Blood.
[6] M. Torres,et al. Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.
[7] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[8] P. Parham,et al. Human-Specific Evolution and Adaptation Led to Major Qualitative Differences in the Variable Receptors of Human and Chimpanzee Natural Killer Cells , 2010, PLoS genetics.
[9] Chap T Le,et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. , 2010, Blood.
[10] Joseph C. Sun,et al. Immune memory redefined: characterizing the longevity of natural killer cells , 2010, Immunological reviews.
[11] K. Hsu,et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. , 2010, Blood.
[12] W. Bodmer,et al. Nomenclature for factors of the HLA system, 2010 , 2010, Tissue antigens.
[13] Justine R. Smith,et al. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy. , 2010, Investigative ophthalmology & visual science.
[14] D. Gjertson,et al. Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. , 2010, Human immunology.
[15] R. Levinson,et al. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals. , 2010, Human immunology.
[16] P. Parham,et al. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands , 2009, Proceedings of the National Academy of Sciences.
[17] D. Bushnell,et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C , 2009, The Journal of experimental medicine.
[18] E. Reed,et al. KIR gene content diversity in four Iranian populations , 2009, Immunogenetics.
[19] Ronald W Davis,et al. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. , 2009, Genome research.
[20] M. Martinetti,et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. , 2009, Blood.
[21] S. Ogawa,et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. , 2009, Blood.
[22] M. Labopin,et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia , 2009, Leukemia.
[23] A Steinle,et al. NK cells and cancer immunosurveillance , 2008, Oncogene.
[24] D. Middleton,et al. Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes , 2008, Genes and Immunity.
[25] Eric O Long,et al. Line of attack: NK cell specificity and integration of signals. , 2008, Current opinion in immunology.
[26] C. Amos,et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. , 2008, Molecular immunology.
[27] R. Pitchappan,et al. Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations , 2008, Immunogenetics.
[28] M. Carrington,et al. Comparison of the rapidly evolving KIR locus in Parsis and natives of India , 2008, Immunogenetics.
[29] P. Parham,et al. Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL31 , 2008, The Journal of Immunology.
[30] D. Gjertson,et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals , 2008, Genes and Immunity.
[31] Ronald W. Davis,et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans , 2007, Nature Genetics.
[32] K. Kidd,et al. Global diversity and evidence for coevolution of KIR and HLA , 2007, Nature Genetics.
[33] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[34] L. Sena,et al. Amazonian Amerindians exhibit high variability of KIR profiles , 2007, Immunogenetics.
[35] G. Gastl,et al. Impact of natural killer cell dose and donor killer‐cell immunoglobulin‐like receptor (KIR) genotype on outcome following human leucocyte antigen‐identical haematopoietic stem cell transplantation , 2007, Clinical and experimental immunology.
[36] P. Gourraud,et al. KIR haplotype content at the allele level in 77 Northern Irish families , 2007, Immunogenetics.
[37] M. Carrington,et al. Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 , 2007, The Journal of Immunology.
[38] D. Gjertson,et al. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans , 2006, Immunogenetics.
[39] D. Middleton,et al. Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.
[40] J. Goedert,et al. KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections , 2006, PLoS pathogens.
[41] M. Caligiuri,et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[42] R. Vance,et al. Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.
[43] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[44] P. Parham,et al. High KIR diversity in Amerindians is maintained using few gene-content haplotypes , 2006, Immunogenetics.
[45] P. Parham,et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function , 2006, The Journal of experimental medicine.
[46] W. Yokoyama,et al. How do natural killer cells find self to achieve tolerance? , 2006, Immunity.
[47] Eric O Long,et al. Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G , 2005, PLoS biology.
[48] P. Parham,et al. KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand1 , 2005, The Journal of Immunology.
[49] M. Ståhle,et al. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. , 2005, The Journal of investigative dermatology.
[50] Eric Vivier,et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[52] T. Tabira,et al. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.
[53] F. Zhu,et al. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. , 2005, Tissue antigens.
[54] D. Whang,et al. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. , 2005, Human immunology.
[55] L. Moretta,et al. Killer immunoglobulin-like receptors. , 2004, Current opinion in immunology.
[56] Salim I. Khakoo,et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.
[57] K. Tung,et al. Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex1 , 2004, The Journal of Immunology.
[58] M. Mańczak,et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. , 2004, Human immunology.
[59] S. Rowland-Jones,et al. Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific , 2004, European journal of immunology.
[60] T. Krieg,et al. Association of killer cell immunoglobulin-like receptors with scleroderma. , 2004, Arthritis and rheumatism.
[61] T. Sasazuki,et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. , 2004, The Journal of investigative dermatology.
[62] R. Tan,et al. Regulation of Autoimmune Diabetes by Complete Freund’s Adjuvant Is Mediated by NK Cells , 2004, The Journal of Immunology.
[63] Stephen J O'Brien,et al. The influence of HLA genotype on AIDS. , 2003, Annual review of medicine.
[64] F. Appelbaum,et al. The current status of hematopoietic cell transplantation. , 2003, Annual review of medicine.
[65] Akiko Kikuchi-Maki,et al. KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production1 , 2003, The Journal of Immunology.
[66] B. Koeleman,et al. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. , 2003, Diabetes.
[67] R. Handgretinger,et al. T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation , 2003, British journal of haematology.
[68] Franco Locatelli,et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. , 2003, Blood.
[69] P. Parham,et al. Human KIR sequences 2003 , 2003, Immunogenetics.
[70] Lewis L Lanier,et al. Natural killer cell receptor signaling. , 2003, Current opinion in immunology.
[71] K. Hsu,et al. The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism , 2002, Immunological reviews.
[72] A. Moffett-King. Natural killer cells and pregnancy , 2002, Nature Reviews Immunology.
[73] Daniel J Weisdorf,et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. , 2002, Blood.
[74] Eric Mickelson,et al. Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1 , 2002, The Journal of Immunology.
[75] P. Parham,et al. Predominance of group AKIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression , 2002, Immunogenetics.
[76] P. Parham,et al. Variable receptors controlling activation and inhibition of NK cells. , 2002, Current opinion in immunology.
[77] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[78] Eric O Long,et al. KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential , 2002, The Journal of Immunology.
[79] Markus Uhrberg,et al. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes , 2002, Immunogenetics.
[80] Katia Perruccio,et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.
[81] Heather G. Shilling,et al. Allelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype1 , 2002, The Journal of Immunology.
[82] P. Parham,et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus , 2002, Immunogenetics.
[83] Michael Bunce,et al. Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.
[84] J. McCluskey,et al. Genomic diversity of natural killer cell receptor genes in three populations. , 2001, Tissue antigens.
[85] William H. Carr,et al. Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.
[86] J. Klein,et al. The HLA system. Second of two parts. , 2000 .
[87] F. Shi,et al. Natural killer cells determine the outcome of B cell–mediated autoimmunity , 2000, Nature Immunology.
[88] S. Beck,et al. Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[89] R. Biassoni,et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[90] Eric O Long,et al. A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells , 1999, The Journal of experimental medicine.
[91] M. Leach,et al. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. , 1998, Journal of immunology.
[92] Eric O Long,et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. , 1998, Journal of immunology.
[93] P Parham,et al. Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.
[94] P Parham,et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.
[95] P. Parham,et al. Natural killer cells, HLA class I molecules, and marrow transplantation. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[96] Wiklund Ra,et al. First of two parts , 1997 .
[97] Eric O Long,et al. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. , 1997, Journal of immunology.
[98] R. Biassoni,et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer , 1996, The Journal of experimental medicine.
[99] Eric O Long,et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.
[100] P. Parham,et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.
[101] G. Ferrara,et al. NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 , 1994, The Journal of experimental medicine.
[102] G. Ferrara,et al. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[103] R. Herberman,et al. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells , 1975, International journal of cancer.
[104] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.
[105] Andrew Glass,et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci , 2005 .
[106] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[107] P. Parham,et al. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. , 2002, Critical reviews in immunology.
[108] R. Vance,et al. Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.
[109] P. Parham,et al. Genetic control of human NK cell repertoire , 2001 .
[110] H J Alter,et al. Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.
[111] J. Klein,et al. The HLA system. First of two parts. , 2000, The New England journal of medicine.
[112] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[113] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[114] C. Dosne Pasqualini. The HLA system. , 1979, Medicina.